Viewing Study NCT00735501


Ignite Creation Date: 2025-12-18 @ 5:45 AM
Ignite Modification Date: 2025-12-23 @ 9:49 PM
Study NCT ID: NCT00735501
Status: None
Last Update Posted: 2014-10-29 00:00:00
First Post: 2008-08-13 00:00:00
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Observational Study to Observe the Safety of LevemirĀ® Treatment in Patients With Type 2 Diabetes
Sponsor: None
Organization:

Study Overview

Official Title: Safety of LevemirĀ® (Insulin Detemir) Treatment in Patients With Type 2 Diabetes
Status: None
Status Verified Date: 2014-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This observational study is conducted in Europe. The study aims to observe the incidence of serious adverse drug reactions in subjects with type 2 diabetes during LevemirĀ® treatment.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: